Ottawa, ON - TheNewswire - March 11, 2022 - Molecule Holdings Inc. (CSE:MLCL) (OTC:EVRRF) ("Molecule" or the "Company"), a Canadian craft-focused cannabis beverage production company, is pleased to announce the launch of its newly revamped website. The new website provides a refreshed design, improved navigation, updated information, and mobile friendly functionality. All our individual brand sites will intuitively link off the Molecule Corporate site to provide an in-depth picture of the business while providing the look and feel of each brands individual nature.
Commented David Reingold, CEO Molecule, "We are happy to have this important project completed. Our corporate website and social channels are a significant conduit for reaching and teaching consumers about our brands and the legal cannabis market. The comprehensive investor section on the website is ideal for staying on top of company news and our evolving success. With this project firmly behind us, we are eager to share our brand specific sites in the coming weeks."
For further information, please contact:
André Audet, Chairman and Co-Founder Phone: 1 (888) 665-2853 x101
Email: andre@molecule.ca www.molecule.ca
About Molecule Holdings Inc.
Molecule is a licensed producer dedicated to creating cannabis-infused beverages for the Canadian market. We produce leading, top-quality drinks to provide opportunity and choice to people seeking a convenient and social way to consume cannabis. Molecule is focused on growing both our portfolio, and the overall cannabis beverage market. We want to ensure people have the best opportunity to find exactly the product and experience they thirst for.
Neither the Canadian Securities Exchange nor its regulation services provider accepts responsibility for the adequacy or accuracy of this press release.
Forward-Looking Statements
This press release contains statements that constitute "forward-looking information" ("forward-looking information") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking information and are based on expectations, estimates and projections as at the date of this news release. Any statement that discusses predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking information. Forward-looking statements in this news release include statements relating to the new Molecule website; the anticipated functionality of the new website; the ability to find information on the website and that that information will be relevant and current. In disclosing the forward-looking information contained in this press release, the Company has made certain assumptions.
The Company's actual results could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which the Company operates, prevailing economic conditions, and other factors, many of which are beyond the control of the Company. The Company believes that the expectations reflected in the forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward-looking information contained in this news release represents the Company's expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
Copyright (c) 2022 TheNewswire - All rights reserved.